iKang Healthcare Group (NASDAQ: KANG) is one of 45 publicly-traded companies in the “Healthcare Facilities & Services” industry, but how does it contrast to its peers? We will compare iKang Healthcare Group to related companies based on the strength of its risk, profitability, valuation, dividends, earnings, analyst recommendations and institutional ownership.

Earnings & Valuation

This table compares iKang Healthcare Group and its peers top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
iKang Healthcare Group $435.71 million -$11.25 million -111.53
iKang Healthcare Group Competitors $6.46 billion $196.14 million 423.12

iKang Healthcare Group’s peers have higher revenue and earnings than iKang Healthcare Group. iKang Healthcare Group is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.


This table compares iKang Healthcare Group and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
iKang Healthcare Group 0.79% 1.30% 0.60%
iKang Healthcare Group Competitors 12.57% 0.26% 1.61%

Analyst Ratings

This is a breakdown of recent ratings for iKang Healthcare Group and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iKang Healthcare Group 0 0 0 0 N/A
iKang Healthcare Group Competitors 250 1464 1979 38 2.48

As a group, “Healthcare Facilities & Services” companies have a potential upside of 4.03%. Given iKang Healthcare Group’s peers higher possible upside, analysts plainly believe iKang Healthcare Group has less favorable growth aspects than its peers.

Volatility and Risk

iKang Healthcare Group has a beta of 0.26, meaning that its stock price is 74% less volatile than the S&P 500. Comparatively, iKang Healthcare Group’s peers have a beta of 0.68, meaning that their average stock price is 32% less volatile than the S&P 500.

Institutional & Insider Ownership

34.3% of iKang Healthcare Group shares are owned by institutional investors. Comparatively, 69.6% of shares of all “Healthcare Facilities & Services” companies are owned by institutional investors. 30.2% of iKang Healthcare Group shares are owned by insiders. Comparatively, 15.7% of shares of all “Healthcare Facilities & Services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.


iKang Healthcare Group peers beat iKang Healthcare Group on 8 of the 10 factors compared.

About iKang Healthcare Group

iKang Healthcare Group, Inc. provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services. The Company, through its integrated service platform, offers healthcare management solutions, including medical examinations, which cover basic examination items, such as internal, gynecology, ophthalmology, dental and X-ray, and value-added services at selected medical centers, including disease screening focusing on cancer screening, cardiovascular disease screening, certain chronic disease screening and functional medicine testing; dental care, including oral health, pediatric dentistry and cosmetic dentistry; outpatient services, such as acupuncture, obstetrics, gynecology and minor surgery, and on-site healthcare management or clinics at certain locations.

Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.